EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk 4/9/2024
AbbVie’s Humira Loses Only 4% of Market Share to Biosimilars: Report 4/9/2024
Lilly Pays $3.2B to Buy Morphic and Deepen Immunology, Gastro Portfolio 7/8/2024
Grifols Gets $6B Takeover Offer from Founding Family, Brookfield to Go Private 7/8/2024
Myricx Bio Raises $115M in Series A to Advance ADC With Lilly and Novo Backing 7/8/2024
GLP-1s May Cut Risk of 10 Obesity-Related Cancers in Diabetes Patients: Study 7/8/2024
Roche Axes Phase II/III NSCLC Study as TIGIT Drug Loses to Keytruda-Chemo Combo 7/8/2024
Boehringer Ingelheim Loses Legal Challenge to IRA in Federal Court Ruling 7/8/2024
Beyond GLP-1s: The Next Obesity Treatments 7/8/2024
Drug Developers Tap the Immune System to Supercharge ADCs 7/8/2024
Patient Assistance Programs: A Source of Real-World Data? 7/8/2024
Regeneron’s Gene Therapy Shows ‘Dramatic’ Hearing Improvement in Deaf Kids 5/8/2024
ASGCT2024: FDA’s Marks on Accelerated Approval, Gene Therapy Costs and More 5/8/2024
Sarepta Seeks Label Expansion, Bigger Market for DMD Gene Therapy 5/8/2024
AstraZeneca Withdraws COVID-19 Vaccine Worldwide as Demand Craters 5/8/2024
Pfizer Halts Dosing in Late-Stage DMD Study Following Death of Young Patient 5/8/2024
Lykos Therapeutics’ MDMA Therapy for PTSD to Face FDA Adcomm 5/8/2024
ASGCT, Adcomm for Lilly’s Donanemab, Vertex Vs. Bluebird 5/8/2024
Generative AI Finds Its Footing in Drug Development 5/8/2024
BMS, J&J Losses Not the End of IRA Legal Battle 5/8/2024